Custom-fitted oral appliances reduce airway obstruction by physically repositioning the lower jaw or tongue forward during ...

The launch of Cloudcure's companion app marks the first step in the company's broader roadmap that will introduce additional clinical and technological capabilities. The company is developing features ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDTCompany ParticipantsAdam Steensberg - President ...

Kiosk-based cannabis access for seniors can be a positive development only if it is embedded within a medically supervised, ...

Barclays 28th Annual Global Healthcare Conference March 12, 2026 11:30 AM EDTCompany ParticipantsDinesh Patel - ...

The Hoffman Process, popular with a growing number of CEOs and celebrities, is often described as ‘10 years of therapy in a week.’ ...

TerSera Therapeutics LLC today announced that it has completed the previously announced sale of its Infusion Specialty Therapies Business Unit (IST), including two specialty medications, Prialt(R) ...

Discover emerging therapies for hyperkalaemia to enhance chronic kidney disease and heart failure management on World Kidney Day.

We are very encouraged by the outcome of our End-of-Phase 2 meeting and the constructive feedback supporting our planned Phase 3 trial for canvuparatide,” said Sam Azoulay, M.D., Chief Medical Officer ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for isolated dystonia and for Parkinson’s disease ...

Evidence is provided suggesting that aggregate neural activity at an early stage of visual processing (V1) can directly contribute to perceptual decisions in humans.